|
|
 |
|
 |
|
|
|
|
Title:
|
Myeloma Specimen Repository Protocol, Ancillary - IRB# 04-112B
|
|
Treatments:
|
-- none --
|
|
Disease Site:
|
Multiple myeloma
|
|
Disease SubSite:
|
Myeloma Specimen Repository
|
|
Drug Provided:
|
-- none --
|
|
Comments:
|
SWOG (Reimbursement for the submission of specimens to this banking protocol will be made based on the requirements of each associated treatment protocol).
|
|
Eligibility:
|
Pts must be currently registered on a Southwest Oncology Group treatment study (SWOG or Intergroup) for multiple myeloma, smoldering myeloma, Waldenstrom's macroglobulinemia, monoclonal gammopathy of undetermined significance, or amyloidosis. Pts who are already enrolled on active SWOG treatment protocols are eligible for this study. A minimum of 3 ml of bone marrow aspirate and at least one tube of blood (preferably two tubes of blood), will be collected from each pt. Pretreatment specimens must be submitted to be eligible for this study. A pt may be registered on this protocol only once. If a pt on this study subsequently enters another treatment protocol related to this study, then specimens can be submitted according to the procedures of this protocol, and the pt need not be registered again on this study.
|
|
Participating Sites:
|
Adventist Medical Center, Northwest Cancer Specialists, Providence Milwaukie Hospital, Providence Portland Medical Center, Providence St. Vincent Medical Center, Southwest Washington Medical Center
|
|
|
|
|
 |
|
 |
|
|
|